Delivery Order 36F79724D0191-36C26026F0025
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $171K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of HETLIOZ (tasimelteon), a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to the prime contractor, Vanda Pharmaceuticals Inc., doing business as Vanda, on October 1, 2024. The contract has a ceiling value of $162,771.05 and a performance period extending through September 30, 2025. This award is a delivery order placed against Vanda's existing GSA Federal Supply Schedule contract for...
- The Department of Veterans Affairs (VA) awarded a $77,798.53 delivery order contract to Vanda Pharmaceuticals Inc. (Vanda) for the provision of HETLIOZ 20MG CAPSULE. This contract is issued against Vanda's Pharmaceuticals and Drugs GSA Schedule contract and has no set-aside designation. Vanda, a global biopharmaceutical company, is the manufacturer of HETLIOZ, a medication used to treat Non-24-Hour Sleep-Wake Disorder in patients served by the VA. This delivery order has a completion date of...
- This federal contract award from the Department of Veterans Affairs (VA) to Vanda Pharmaceuticals Inc. (Vanda) is for the delivery of the medication Hetlioz (tasimelteon) to the VA's Veterans Integrated Service Network 16. The $128,543.49 delivery order contract is a firm fixed-price instrument placed against Vanda's Pharmaceuticals and Drugs GSA Schedule contract. Hetlioz is used to treat Non-24-Hour Sleep-Wake Disorder, a condition affecting many veterans. This award is not designated as a...
- This is a firm fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The award is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract has a ceiling value of...
- This federal contract award was made by the Veterans Health Administration, a component of the U.S. Department of Veterans Affairs, to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price of $10,418.14 and a completion date of August 22, 2025. It is part of a larger Blanket Purchase Agreement (BPA) valued at $25,000,000 and an Indefinite-Delivery Indefinite-Quantity (IDIQ)...
- This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...
- This is a firm-fixed-price delivery order awarded to Harmony Biosciences, LLC by the Department of Veterans Affairs (VA) Veterans Health Administration. The order is against the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a ceiling value of $30,510.72. The order is for the supply of PITOLISANT (WAKIX) 17.8MG TAB NDC: 72028-0178-03, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony Biosciences is a...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract, valued at $10,418.14, is for the delivery of WAKIX 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued under Harmony Biosciences' Federal Supply Schedule (FSS-61-IB) for...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The $10,418.40 order is for WAKIX 17.8 MG tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The order is issued against Harmony Biosciences' General Services Administration Federal Supply...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract, valued at $5,085.00, is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients....